Sign in

CIK 0001678660

  • Non-accelerated filer
  • Smaller reporting company

Prelude Therapeutics Inc

Sign in to watch
Ticker
PRLD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
811384762
Phone
+1 302-467-1280
Business address
175 INNOVATION BOULEVARD, WILMINGTON, DE, 19805
Former names
Prelude Therapeutics Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-04-21 ORBIMED ADVISORS LLC Director Purchase +1,689,189 $4.44 $7.5M 11,808,945
2026-04-21 ORBIMED ADVISORS LLC Director Purchase +1,126,126 $4.44 $5.0M 1,126,126
2023-05-22 ORBIMED ADVISORS LLC Director Purchase +869,565 $5.75 $5.0M 10,119,756
2021-01-11 ORBIMED ADVISORS LLC Director Purchase · Non-Voting Common Stock +41,700 $60.00 $2.5M 5,596,886
2020-09-29 ORBIMED ADVISORS LLC Director Conversion +8,332,779 9,250,191
2020-09-29 ORBIMED ADVISORS LLC Director Conversion · Series A Preferred Stock −3,294,743 0
2020-09-29 ORBIMED ADVISORS LLC Director Conversion · Series A Prefered Stock −2,196,494 0
2020-09-29 ORBIMED ADVISORS LLC Director Conversion · Series B Preferred Stock −4,418,186 0
2020-09-29 ORBIMED ADVISORS LLC Director Conversion · Series B Preferred Stock −2,945,458 0
2020-09-29 ORBIMED ADVISORS LLC Director Conversion · Series C Preferred Stock −619,850 0
2020-09-29 ORBIMED ADVISORS LLC Director Conversion · Series C Preferred Stock −413,234 0
2020-09-29 ORBIMED ADVISORS LLC Director Conversion · Non-Voting Common Stock +5,555,186 5,555,186
2020-09-25 ORBIMED ADVISORS LLC Director Purchase +526,300 $19.00 $10.0M 526,300
2020-09-25 ORBIMED ADVISORS LLC Director Purchase +710,500 $19.00 $13.5M 917,412
2020-08-21 ORBIMED ADVISORS LLC Director Purchase · Series C Preferred Stock +1,033,084 1,033,084
2020-03-27 ORBIMED ADVISORS LLC Director Purchase · Series B Preferred Stock +3,681,822 7,363,644

Page 1 of 1 · 16 trades